Alaleh Nouri sold $2.7M of PRCT
EVP, CLO, CORP. SEC. at PROCEPT BioRobotics Corp. 28,092 shares at an average of $97.13, traded Dec 4, 2024, filed Dec 6, 2024.
Score components
- +15RoleOfficer
- +25Trade size$2.7M at market
- +10Share of holdings soldSold 35% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -11.1%, 3m -37.4%, 6m -33.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-24-050221, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 4, 2024 | MOption exercise Common Stock10b5-1 | +11,838 | $7.27 | $86k | 64,310 | Dec 6, 2024 |
| Dec 4, 2024 | MOption exercise Common Stock10b5-1 | +4,162 | $34.99 | $146k | 68,472 | Dec 6, 2024 |
| Dec 4, 2024 | MOption exercise Common Stock10b5-1 | +12,092 | $37.02 | $448k | 80,564 | Dec 6, 2024 |
| Dec 4, 2024 | SOpen-market sale Common Stock10b5-1 | -3,787 | $96.12 | $364k | 76,777 | Dec 6, 2024 |
| Dec 4, 2024 | SOpen-market sale Common Stock10b5-1 | -16,187 | $96.98 | $1.6M | 60,590 | Dec 6, 2024 |
| Dec 4, 2024 | SOpen-market sale Common Stock10b5-1 | -8,118 | $97.90 | $795k | 52,472 | Dec 6, 2024 |
| Dec 4, 2024 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -11,838 | $0.00 | $0 | 21,056 | Dec 6, 2024 |
| Dec 4, 2024 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -4,162 | $0.00 | $0 | 2,728 | Dec 6, 2024 |
| Dec 4, 2024 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -12,092 | $0.00 | $0 | 26,094 | Dec 6, 2024 |
Related signals
Other insiders at PROCEPT BioRobotics Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | PROCEPT BioRobotics Corp | Alaleh Nouri EVP, CLO, CORP. SEC. | $6,223 297 shares | -0% | |
| 30Weak | PROCEPT BioRobotics Corp | Barry L Templin EVP, Chief Technology Officer | $7,815 373 shares | -0% | |
| 37Weak | PROCEPT BioRobotics Corp | Kevin Waters EVP, CFO | $7,815 373 shares | -0% | |
| 59Moderate | PRCTbuy PROCEPT BioRobotics Corp | Larry L Wood President, CEO | $498k 23,900 shares | - | |
| 30Weak | PROCEPT BioRobotics Corp | Alaleh Nouri EVP, CLO, CORP. SEC. | $8,117 285 shares | -0% | |
| 30Weak | PROCEPT BioRobotics Corp | Barry L Templin EVP, Chief Technology Officer | $10k 358 shares | -1% | |
| 37Weak | PROCEPT BioRobotics Corp | Kevin Waters EVP, CFO | $10k 357 shares | -0% | |
| 23Weak | PROCEPT BioRobotics Corp | Alaleh Nouri EVP, CLO, CORP. SEC. | $8,559 304 shares | -0% | |
| 14Weak | PROCEPT BioRobotics Corp | Alaleh Nouri EVP, CLO, CORP. SEC. | $139k 5,363 shares | -5% | |
| 30Weak | PROCEPT BioRobotics Corp | Kevin Waters EVP, CFO | $20k 706 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.